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Summary
The advent of retrievable caval filters was a game changer
in the sense, that the previously irreversible act of implant-
ing a medical device into the main venous blood stream of
the body requiring careful evaluation of the pros and cons
prior to execution suddenly became a “reversible“ proced-
ure where potential hazards in the late future of the pa-
tient lost most of their weight at the time of decision mak-
ing. This review was designed to assess the rate of success
with late retrieval of so called retrievable caval filters in or-
der to get some indication about reasonable implant dura-
tion with respect to relatively “easy“ implant removal with
conventional means, i.e., catheters, hooks and lassos. A
PubMed search (www.pubmed.gov) was performed with
the search term „cava filter retrieval after 30 days clinic-
al“, and 20 reports between 1994 and 2013 dealing with
late retrieval of caval filters were identified, covering ap-
proximately 7,000 devices with 600 removed filters. The
maximal duration of implant reported is 2,599 days and the
maximal implant duration of removed filters is also 2,599
days. The maximal duration reported with standard retriev-
al techniques, i.e., catheter, hook and/or lasso, is 475 days,
whereas for the retrievals after this period more sophist-
icated techniques including lasers, etc. were required. The
maximal implant duration for series with 100% retrieval
accounts for 84 days, which is equivalent to 12 weeks or
almost 3 months. We conclude that retrievable caval fil-
ters often become permanent despite the initial decision
of temporary use. However, such “forgotten“ retrievable
devices can still be removed with a great chance of success
up to three months after implantation. Conventional per-
cutaneous removal techniques may be sufficient up to six-
teen months after implantation whereas more sophisticated
catheter techniques have been shown to be successful up to
83 months or more than seven years of implant duration.
Tilting, migrating, or misplaced devices should be removed
early on, and replaced if indicated with a device which is
both, efficient and retrievable.
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Introduction
The main indications for implantation of a caval filter
(fig. 1) in the presence of proven venous thrombo-emboli
include A) recurrent pulmonary emboli despite efficient
anticoagulation B) contra-indication of anticoagulation in
the presence of pulmonary emboli C) complication of an-
ticoagulation D) inability to achieve or maintain adequate
anticoagulation [1]. However, the indications are only part
of the parameters of the equation about the usefulness of
caval filtration in a specific patient. As a matter of fact, and
based on our own experience, there are also a number of
concerns related to the caval filters themselves including
filter dislodgement, filter penetration, filter fracture, ven-
ous thrombo-embolic events originating from the caval fil-
Figure 1
Original Greenfield vena cava filter (catalog no. 2846). This device
was designed for permanent implantation including sharp hooks at
the bottom to prevent migration. In contrast, retrievable caval filters
have a hook or a graspable area at the tip that allows for traction
and refolding into a sheath.
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ter, complete thrombosis of the vena cava related to the
caval filter, etc. Hence, the advent of retrievable caval fil-
ters in the sixties of the last century [2] was a game changer
in the sense, that the previously irreversible act of implant-
ing a medical device into the main venous blood stream of
the body requiring careful evaluation of the pros and cons
prior to execution suddenly became a “reversible“ proced-
ure where potential hazards in the late future of the patient
lost most of their weight at the time of decision making.
This does not mean that late problems related to caval fil-
ters vanished [3, 4]. As a matter of fact it turned out in
our clinical practice that so-called retrievable caval filters
typically designed and approved for use for two or three
weeks (less than 30 days) were often left in situ and thus
became permanent. It is only at the occasion of complica-
tions or new health problems that the retrieval of the ori-
ginally temporary caval filter was reconsidered, and some-
times attempted. The present review was designed to assess
the rate of success with late retrieval of so called retriev-
able caval filters in order to get some indication about reas-
onable implant duration with respect to relatively “easy“
implant removal with conventional means, i.e., catheters,
hooks and lassos.
Search strategy
In order to assess the rate of success with late retrieval
of temporary caval filters, a PubMed search
(www.pubmed.gov) was performed on 13 October 2013,
with the search term “cava filter retrieval after 30 days clin-
ical“. This search term was based on the rational that the
most frequent venous filter deployment site is the inferior
vena cava, that the retrievable caval filters are typically de-
signed for an implant duration of 15 ± 10 days, and that
the 30 days implant interval is a regulatory hurdle with less
stringent criteria for medical devices designed for less than
30 days implant duration.
Results
The search described above identified 20 reports between
1994 and 2013 dealing with late retrieval of caval filters.
Figure 2
Proportion of filters removed over time. It is interesting to note, that
up to 84 days, 100% filter removal can be obtained by conventional
means (hooks and lassos).
The 15 reports providing sufficiently detailed information
about the number of implants, the filter position, the mean
and/or range of implant duration, the proportion of success-
fully removed filters, and the number of not removed filters
with the reason for failure if available are shown in table
1. This compilation covers approximately 7,000 devices.
The total number of removed filters in table 1 accounts for
600 devices. The maximal duration of implant reported is
2,599 days and the maximal implant duration of removed
filters is also 2,599 days. The maximal duration reported
with standard retrieval techniques, i.e., catheter, hook and/
or lasso, is 475 days, whereas for the retrievals after this
period more sophisticated techniques including lasers etc.
were required. The key problem in failure to remove re-
trievable caval filters appears to be the position of the fil-
ter tip or key filter part designed for re-folding the device.
We can tell from our experience, that tips of tilted filters
tend to sink into the caval wall and can become overgrown,
thus making capture difficult. The maximal implant dura-
tion for series with 100% retrieval (fig. 2) accounts for 84
days, which is equivalent to 12 weeks or almost 3 months
(table 2).
In our experience, there are many good reasons for post-
poning early removal of retrievable caval filters including
patent foramen ovale and/or other intra-cardiac right to left
shunts, presence of clot within the caval filter at the time of
planned removal, unresolved deep vein thrombosis, persist-
ent pulmonary hypertension, persistent respiratory insuffi-
ciency, unstable anticoagulation and others.
Discussion
The most striking finding of this review is the fact, that re-
trievable caval filters designed for temporary caval filtra-
tion of two or three weeks (less than 30 days) have been
successfully removed in all cases where this was attemp-
ted, in several series [6, 7, 11, 13, 14] as many as 12 weeks
after insertion. This includes Celect, Bard, Gunther, Tempo
and other filter brands. Although this does not mean that
the caval filters designed for short term use should be im-
planted routinely for long term use, it is extremely helpful
for clinical practice to know, that the regulatory threshold
of 30 days for temporary caval filtration by the means of
a retrievable caval filter is not written in stone for clinical
reasons. There can be no doubt, that temporary caval fil-
tration of three weeks which may be extended to almost
three months without compromising the rate of removal re-
duces the pressure of too early a removal of the intra-cav-
al device, when this may still be required, or the removal
process is contra-indicated at a specific moment for some
other reason [20], provided that the device considered is
designed for longer term use or later conversion to a non-
filtering device.
Interestingly enough, there are other devices, that are left
in the vena cava for some time and are therefore designed
to be removed sooner or later, like intravascular gas ex-
changers [21] built for temporary extra-pulmonary gas
transfer, which can be removed by simple traction after
more than 28 days [22], venous cannulas used for extra-
corporeal membrane oxygenation including collapsible
designs, which can also be removed by simple traction after
Review article: Current opinion Swiss Med Wkly. 2014;144:w14022
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 2 of 6
as many as 28 days [23–25]. In contrast, permanent im-
plants in the vena cava like catheters connected to valves
or ports, pace maker leads, as well as defibrillator leads can
become very difficult for late removal in toto and may re-
quire special expertise as well as specific instrumentation
including lasers, threaded stylets, cutting sheaths, etc.
These more complex removal procedures bring us to the
second important finding of this review. As a matter of fact,
even caval filters implanted for 2,599 days can be removed
without open surgery but with specific trans-luminal tech-
niques after this period of indwelling, whereas standard re-
trieval techniques may still work after an implant duration
of up to 475 days (table 2).
There are a number of additional observations listed in
table 1 which deserve to be highlighted. The review of An-
gel LF covered 6,834 implants of multiple brands, but did
not reveal a markedly superior design. Two reports with
smaller series mentioned strut fractures [6, 15]. The latter
can migrate and may require surgical removal under cer-
tain circumstances. One key reason for problems with the
removal of retrievable caval filters appears to be the posi-
tion of the filter tip or key filter part designed for re-fold-
ing the device. The latter can be difficult to capture if it ad-
heres to the venous wall [10] a situation which is favoured
if the filter is tilted with reference to the caval axis. In such
a situation the point of traction designed for capture by the
retrieval device (typically a hook) may be flush to the cav-
al wall, or even hidden in intramural fashion. With a tilted
device, even the approach with a lasso from the other side,
may be difficult or impossible and therefore it may not be
possible to be snared and reloaded into a sheath. It is a fact
that stent arms and arches driven by excessive expansion
force (e.g., due to expansion in tilted position) lead to more
media atrophy with intimal overgrowth [25], can penetrate
the basal membrane of the endothelium, and the adventi-
tia, and thus it can be impossible to grab the specific point
of traction designed for device refolding prior to re-loading
into a catheter. Hence, the indication to consider earlier re-
trieval of tilted retrievable caval filters where overgrowth
of the key components designed for device collapsing are
risking success with standard retrieval techniques, and to
avoid more complex interventions including open surgery.
We conclude that retrievable caval filters often become per-
manent. However, such ”forgotten“ retrievable devices can
still be removed by conventional catheter techniques with
a great chance of success up to three months after im-
plantation. Conventional percutaneous removal techniques
may be sufficient up to sixteen months after implantation
whereas more sophisticated catheter techniques have been
shown to be successful up to 83 months or more than seven
years of implant duration. Tilting, migrating, or misplaced
devices should be removed early on, and replaced if indic-
ated with a device which is both, efficient and retrievable.
Our preference goes for retrievable or convertible tempor-
ary caval filters designed for optional permanent implanta-
tion.
Funding / potential competing interests: No financial support
and no other potential conflict of interest relevant to this article
was reported.
Table 1: Main findings for duration and success of removal with various filter types.
Reference Year
published
Author Filter brand No. devices Position Duration
Mean
Range Removed Not removed
days days cause
5 2013 Smouse HB Crux 54 Cava 84.6 ± 57.6 6–190 53/54 1 remained
6 2013 Kuo WT X 50 Cava 815 20–2599 50/50 fractures > 1y
7 2011 Van Ha TG X 20 Iliac 40±10 30–71 all none
8 2011 Angel LF X 6,834 Cava NA NA no superior
design
9 2010 Johnson MS Option 39 Cava 67 1–175 36/39 3 remained
10 2009 Binkert CA G2 61 Cava 140 5–300 58/61 3 tip at wall
11 2009 Sangwaiya MJ Celect 14 Cava 84 6–190 14/14 none
12 2007 Yamagami T Gunther 80 Cava 13.4 ± 4.2 NA 77/80 3 remained
13 2007 Piano G Bard/Gu 52 Cava 63 ± 30 NA 52/52 8 refused
14 2006 Bovin G Tempo 103 Cava 29.5 ± 14 2–86 102/103 none <84 d
15 2006 Stefanidis D X 54 Cava 142 17–475 47/54 1 strut fracture
16 2006 De Gregorio M Gunther 32 Cava 30 NA 31/32 1 force > 9.8N
17 2005 Rosenthal D OptEase 40 Cava 16.4 ± 7.2 3–48 40/40 none
18 2005 Imberti D ALN 18 Cava <3 months 14/18
8 Cava >3 months 4/8
19 1994 Nakagawa Nitinol 2 Cava 6 5–7 2/2 none
Table 2: Main findings.
Number of reports 15 reports
Period of reports 1994 and 2013
Number of devices covered 7,000 devices
Total number of removed filters 600 devices
Maximal implant duration 2,599 days
Maximal implant duration of removed filters 2,599 days
Maximal implant duration with standard retrieval 475 days
Maximal implant duration with 100% retrieval 84 days = 12 weeks <3 months
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Figures (large format)
Figure 1
Original Greenfield vena cava filter (catalog no. 2846). This device was designed for permanent implantation including sharp hooks at the
bottom to prevent migration. In contrast, retrievable caval filters have a hook or a graspable area at the tip that allows for traction and refolding
into a sheath.
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Figure 2
Proportion of filters removed over time. It is interesting to note, that up to 84 days, 100% filter removal can be obtained by conventional means
(hooks and lassos).
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